Alan Sharpe

2.2k total citations
37 papers, 1.7k citations indexed

About

Alan Sharpe is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Alan Sharpe has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Alan Sharpe's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (4 papers). Alan Sharpe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (4 papers). Alan Sharpe collaborates with scholars based in United Kingdom, United States and South Korea. Alan Sharpe's co-authors include Mary Keir, Loise M. Francisco, A.M. Riddle, Jill Walker, David Carruthers, Christine McHugh, Jenny Stocker, M. Ratcliffe, Marietta Scott and Craig Barker and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Alan Sharpe

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Sharpe United Kingdom 19 624 397 356 342 289 37 1.7k
Shengping Li China 29 540 0.9× 592 1.5× 104 0.3× 361 1.1× 209 0.7× 70 2.4k
Yifan Zhang China 24 348 0.6× 210 0.5× 197 0.6× 464 1.4× 150 0.5× 132 2.1k
Susan Carroll Australia 20 540 0.9× 236 0.6× 230 0.6× 497 1.5× 181 0.6× 65 1.8k
Ting Zhou China 18 887 1.4× 276 0.7× 535 1.5× 460 1.3× 202 0.7× 133 1.8k
Núria Pardo Spain 19 595 1.0× 191 0.5× 426 1.2× 249 0.7× 149 0.5× 94 1.5k
Andrej Khandoga Germany 28 262 0.4× 624 1.6× 160 0.4× 577 1.7× 151 0.5× 51 2.3k
Yamei Chen China 25 441 0.7× 300 0.8× 166 0.5× 799 2.3× 267 0.9× 86 2.3k
M. Schroeder Germany 23 608 1.0× 129 0.3× 578 1.6× 955 2.8× 634 2.2× 60 2.4k
Andrzej Kulig Poland 19 445 0.7× 179 0.5× 167 0.5× 345 1.0× 327 1.1× 156 1.4k
Junlin Li China 19 408 0.7× 105 0.3× 109 0.3× 1.0k 3.0× 225 0.8× 89 2.0k

Countries citing papers authored by Alan Sharpe

Since Specialization
Citations

This map shows the geographic impact of Alan Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Sharpe more than expected).

Fields of papers citing papers by Alan Sharpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Sharpe. The network helps show where Alan Sharpe may publish in the future.

Co-authorship network of co-authors of Alan Sharpe

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Sharpe. A scholar is included among the top collaborators of Alan Sharpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Sharpe. Alan Sharpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Avinash, Frances Willenbrock, Roz Brant, et al.. (2019). Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma. British Journal of Cancer. 122(4). 506–516. 20 indexed citations
2.
Boothman, Anne-Marie, Marietta Scott, M. Ratcliffe, et al.. (2019). Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study. Journal of Thoracic Oncology. 14(8). 1390–1399. 33 indexed citations
3.
Scott, Marietta, M. Ratcliffe, Catherine Wadsworth, et al.. (2018). MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples. Journal of Thoracic Oncology. 13(10). S422–S422.
4.
Ratcliffe, M., Alan Sharpe, Anita Midha, et al.. (2017). Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(14). 3585–3591. 237 indexed citations
5.
Ratcliffe, M., Alan Sharpe, Craig Barker, et al.. (2017). Correction to: Abstracts. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(2). 301–301. 1 indexed citations
6.
Brant, Roz, Alan Sharpe, Jonathan R. Dry, et al.. (2016). Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors. Clinical Cancer Research. 23(6). 1471–1480. 17 indexed citations
7.
Kilgour, Elaine, Helen K. Angell, K.-M. Kim, et al.. (2016). Programmed death-ligand 1 (PD-L1) and immune infiltrates are prognostic for better outcome and enriched in the ATM (ataxia telangiectasia mutated)-low segment of gastric cancer (GC). Annals of Oncology. 27. vi212–vi212. 1 indexed citations
8.
Sharpe, Alan, et al.. (2016). Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality?. BMC Clinical Pathology. 16(1). 17–17. 25 indexed citations
9.
Whitley, David S., et al.. (2016). Quantitative structure-property relationships for predicting sorption of pharmaceuticals to sewage sludge during waste water treatment processes. The Science of The Total Environment. 579. 1512–1520. 33 indexed citations
10.
Hodgson, Darren, Zhongwu Lai, Brian Dougherty, et al.. (2016). Candidate predictive biomarkers for response to olaparib in advanced gastric cancer (AGC).. Journal of Clinical Oncology. 34(15_suppl). 4041–4041. 2 indexed citations
11.
12.
Veldman-Jones, Margaret H., Roz Brant, Claire Rooney, et al.. (2015). Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples. Cancer Research. 75(13). 2587–2593. 234 indexed citations
13.
Sharpe, Alan, et al.. (2015). Effect of sewage sludge type on the partitioning behaviour of pharmaceuticals: a meta-analysis. Environmental Science Water Research & Technology. 2(1). 154–163. 28 indexed citations
14.
Whitley, David S., et al.. (2014). A solid-phase extraction method for rapidly determining the adsorption coefficient of pharmaceuticals in sewage sludge. Water Research. 67. 292–298. 15 indexed citations
15.
Brown, A. Ross, Lisa K. Bickley, Gareth Le Page, et al.. (2011). Are Toxicological Responses in Laboratory (Inbred) Zebrafish Representative of Those in Outbred (Wild) Populations? − A Case Study with an Endocrine Disrupting Chemical. Environmental Science & Technology. 45(9). 4166–4172. 39 indexed citations
16.
Cumming, Rob I., et al.. (2009). Photo-induced environmental depletion processes of β-blockers in river waters. Photochemical & Photobiological Sciences. 8(6). 768–777. 43 indexed citations
17.
Keir, Mary, Loise M. Francisco, & Alan Sharpe. (2007). PD-1 and its ligands in T-cell immunity. Current Opinion in Immunology. 19(3). 309–314. 349 indexed citations
18.
Sharpe, Alan, M. McElroy, Jan Langeveld, et al.. (2004). Immunohistochemical studies of scrapie archival material from Irish ARQ/ARQ sheep for evidence of bovine spongiform encephalopathy-derived disease. Research in Veterinary Science. 79(1). 29–35. 1 indexed citations
19.
Sharpe, Alan, et al.. (2004). Results of a technology demonstration project to compare rapid aquatic toxicity screening tests in the analysis of industrial effluents. Journal of Environmental Monitoring. 6(11). 855–855. 27 indexed citations
20.
Adachi, Tadashi, Hiroaki Takayanagi, & Alan Sharpe. (1997). Ion-exchange high-performance liquid chromatographic separation of protein variants and isoforms on MCI GEL ProtEx stationary phases. Journal of Chromatography A. 763(1-2). 57–63. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengping Li Breakdown of academic impact, for papers by Yifan Zhang Breakdown of academic impact, for papers by Susan Carroll Breakdown of academic impact, for papers by Ting Zhou Breakdown of academic impact, for papers by Núria Pardo Breakdown of academic impact, for papers by Andrej Khandoga Breakdown of academic impact, for papers by Yamei Chen Breakdown of academic impact, for papers by M. Schroeder Breakdown of academic impact, for papers by Andrzej Kulig Breakdown of academic impact, for papers by Junlin Li
Rankless by CCL
2026